Practical advances in stool screening for colorectal cancer

Area of Science:

• Gastroenterology
• Oncology
• Preventive Medicine

Background:

• Colorectal cancer (CRC) screening is crucial for early detection and mortality reduction.
• Colonoscopy is accurate but invasive, leading to patient preference for noninvasive methods.
• Traditional guaiac fecal occult blood tests (gFOBT) have limitations in sensitivity and specificity.

Purpose of the Study:

• To review the evolution and performance of stool-based screening tests for colorectal cancer.
• To compare the efficacy of different noninvasive CRC screening modalities.
• To highlight the growing reliability of stool-based testing in CRC screening strategies.

Main Methods:

• Review of existing literature on colorectal cancer screening tests.
• Comparative analysis of guaiac fecal occult blood tests (gFOBT), fecal immunochemical tests (FITs), and stool DNA tests.
• Evaluation of sensitivity, specificity, and patient preference for various screening methods.

Main Results:

• Fecal immunochemical tests (FITs) offer improved sensitivity and specificity over gFOBT.
• Stool DNA tests demonstrate higher sensitivity for CRC detection compared to gFOBT.
• Advancements in FIT and stool DNA tests are enhancing their performance characteristics.

Conclusions:

• Noninvasive stool-based tests are increasingly preferred for colorectal cancer screening.
• Fecal immunochemical tests (FITs) and stool DNA tests represent significant improvements over traditional methods.
• Stool-based testing is becoming a more reliable component of colorectal cancer screening armamentarium.